Edition:
United States

Concordia International Corp (CXRX.OQ)

CXRX.OQ on NASDAQ Stock Exchange Global Select Market

0.70USD
21 Feb 2018
Change (% chg)

$0.01 (+1.67%)
Prev Close
$0.69
Open
$0.67
Day's High
$0.71
Day's Low
$0.67
Volume
6,025
Avg. Vol
92,992
52-wk High
$2.55
52-wk Low
$0.45

Latest Key Developments (Source: Significant Developments)

Concordia International Says UK Competition, Markets Authority Notified Co It Is Closing Investigation Related To Fusidic Acid Eye Drops
Thursday, 15 Feb 2018 07:26am EST 

Feb 15 (Reuters) - Concordia International Corp ::CONCORDIA INTERNATIONAL CORP - UK COMPETITION AND MARKETS AUTHORITY NOTIFIED CO THAT IT IS CLOSING ITS INVESTIGATION RELATED TO FUSIDIC ACID EYE DROPS.CONCORDIA INTERNATIONAL- ‍BELIEVES COMPETITION LAW IN UK HAS NOT BEEN INFRINGED, INCLUDING IN RELATION TO PRICING OF CO'S MEDICINES​.  Full Article

Concordia International To Defer Payment Of About $37.5 Mln Interest Due Dec 15
Friday, 15 Dec 2017 10:33am EST 

Dec 15 (Reuters) - Concordia International Corp ::CONCORDIA INTERNATIONAL CORP - ‍DETERMINED TO DEFER PAYMENT OF APPROXIMATELY $37.5 MILLION OF INTEREST DUE DEC 15 ON 9.5% SENIOR UNSECURED NOTES​.CONCORDIA INTERNATIONAL CORP - ‍EXPECTED THAT FOREGOING INTEREST PAYMENT WILL BE ADDRESSED AS PART OF ANY RECAPITALIZATION TRANSACTION​.  Full Article

UK CMA says it provisionally found that Concordia overcharged NHS by millions
Tuesday, 21 Nov 2017 02:02am EST 

Nov 21 (Reuters) - UK Competition and Markets Authority -:‍CMA HAS PROVISIONALLY FOUND THAT CONCORDIA ABUSED ITS DOMINANT POSITION TO OVERCHARGE NHS BY MILLIONS FOR ESSENTIAL THYROID DRUG​.UK'S CMA ‍FINDINGS ARE PROVISIONAL AND THERE HAS BEEN NO DEFINITIVE DECISION THAT THERE HAS BEEN A BREACH OF COMPETITION LAW​.UK'S CMA ‍WILL CAREFULLY CONSIDER ANY REPRESENTATIONS FROM COMPANIES BEFORE DECIDING WHETHER LAW HAS IN FACT BEEN BROKEN​.  Full Article

Concordia International ‍comments on UK CMA statement of objections related to Liothyronine
Tuesday, 21 Nov 2017 02:00am EST 

Nov 21 (Reuters) - Concordia International Corp -:‍COMMENTS ON CMA STATEMENT OF OBJECTIONS RELATED TO LIOTHYRONINE; SAYS "DO NOT BELIEVE THAT COMPETITION LAW HAS BEEN INFRINGED​".‍WILL REVIEW CMA'S PRELIMINARY POSITION; CONTINUE TO WORK CO-OPERATIVELY WITH CMA AS IT PROCEEDS WITH ITS INVESTIGATION.​.  Full Article

Concordia International Q3 ‍reported revenue $154.6 mln
Tuesday, 14 Nov 2017 07:00am EST 

Nov 14 (Reuters) - Concordia International Corp :Concordia International announces third quarter 2017 results.Concordia International Corp qtrly ‍reported revenue of $154.6 million, compared to $185.5 million for same period in 2016​.Concordia International Corp qtrly loss per share from continuing operations $1.36​.  Full Article

Concordia International seeks to realign capital structure under CBCA
Friday, 20 Oct 2017 09:47am EDT 

Oct 20 (Reuters) - Concordia International Corp ::Concordia International Corp. takes next step to realign its capital structure by commencing proceedings under the Canada Business Corporations Act.Seeking to reduce its existing secured and unsecured debt obligations by more than $2 billion​.Intends to continue operating its business as usual during CBCA proceedings​.Company had approximately $340 million of cash on hand as of September 30, 2017​.Some ‍payments owed to unsecured lenders will not be paid as scheduled & are expected to be addressed as part of recapitalization.Proposed recapitalization transaction may result in dilution of outstanding common shares of company​.It is commencing a court proceeding under Canada Business Corporations Act​.Under CBCA process, Concordia's management will continue to lead day-to-day operations​.  Full Article

Concordia International-‍ UK CMA investigating into co's international segment
Wednesday, 11 Oct 2017 07:00am EDT 

Oct 11 (Reuters) - Concordia International Corp :Concordia International-‍ UK CMA investigating issues related to UK pharmaceutical sector, co's international segment,certain products part of inquiry​.Concordia International -UK CMA ‍investigation at early, stage,CMA confirmed it has not reached conclusions if competition law been infringed​.  Full Article

Concordia International says ‍UK Competition and Markets Authority investigating pharma sector​
Wednesday, 11 Oct 2017 07:00am EDT 

Oct 11 (Reuters) - Concordia International Corp :Says ‍UK competition and markets authority is investigating new issues in relation to UK pharmaceutical sector​.Says ‍that Concordia's International segment and certain of its products are part of CMA's inquiry​.Says ‍investigation is at an early, information-gathering stage​.Says ‍CMA's investigation includes matters that pre-date Concordia's ownership of international segment​.Concordia International says ‍CMA has confirmed that, at this time, it has not reached any conclusions on whether competition law has been infringed​.  Full Article

Concordia International Corp announces Q2 revenue $160.8 million
Friday, 11 Aug 2017 07:00am EDT 

Aug 11 (Reuters) - Concordia International Corp :Concordia International Corp. announces second quarter 2017 results.Q2 revenue $160.8 million versus $231.7 million.International segment revenue of $115.3 million for three months ended June 30, 2017 decreased by $36.1 million.Qtrly loss per share $19.78‍​.Concordia International - Net loss from operations of $1.01 billion, primarily due to $987.1 million of impairments recorded on goodwill, product rights in quarter.As of June 30, 2017, company had cash of $301.8 million.  Full Article

Concordia International provides update on development of long-term growth strategy
Wednesday, 21 Jun 2017 07:00am EDT 

June 21 (Reuters) - Concordia International Corp ::Concordia International Corp. provides update on development of long-term growth strategy.Says company intends to communicate its details with stakeholders in second half of 2017.Concordia International Corp - company's development of a "long-term growth" strategy is nearing completion.Concordia International Corp - company has engaged perella weinberg partners lp to provide financial advisory services.Concordia International - financial advisory services may include, but are not limited to, helping co explore, evaluate potential transactional alternatives.  Full Article

BRIEF-Concordia International Says UK Competition, Markets Authority Notified Co It Is Closing Investigation Related To Fusidic Acid Eye Drops

* CONCORDIA INTERNATIONAL CORP - UK COMPETITION AND MARKETS AUTHORITY NOTIFIED CO THAT IT IS CLOSING ITS INVESTIGATION RELATED TO FUSIDIC ACID EYE DROPS